NCT03009682
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Small Cell Lung Carcinoma
Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.
820 public trials
197 recruiting studies
Small Cell Lung Carcinoma trial results
NCT03059667
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +10 more
- Locations
-
- Annemasse - CH Ambilly, France
- Angers - CHU Angers, France
- CH Colmar, France
- CHRU Grenoble Grenoble, France
NCT00466466
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- University of Colorado Health Sciences Center Aurora, Colorado, United States
- Dana Faber Cancer Institute Boston, Massachusetts, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT03098030
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Alaska Clinical Research Center Anchorage, Alaska, United States
- Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
- Innovative Clinical Research Institute Tucson, Arizona, United States
- Genesis Cancer Center Hot Springs, Arkansas, United States
NCT03547804
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- The First Hospital Of Jilin University Changchun, Jilin, China
NCT00765973
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
- Locations
-
- Barbara Ann Karmanos Cancer Center Detroit, Michigan, United States
- South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
NCT00415363
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergen, Norway
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trondheim, Norway
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olsztyn, Poland
NCT03538028
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
- Locations
-
- The Angeles Clinic and Research Center Los Angeles, California, United States
- Hackensack Medical Center Hackensack, New Jersey, United States
- Carolina BioOncology Institute Huntersville, North Carolina, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT02499770
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Genesis Cancer Center Hot Springs, Arkansas, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- The Oncology Institute of Hope and Innovation Whittier, California, United States
- Memorial Hospital - Univ. of Colorado Health Colorado Springs, Colorado, United States
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea